Drug Eluting Pantera Lux Catheter Registry

Evaluation of the Safety Profile of the Pantera Lux Paclitaxel Releasing Balloon for Coronary Arteries in Daily Clinical Practice

All comers registry - Evaluation of the safety and efficacy of the Pantera Lux Paclitaxel releasing balloon for coronary arteries in daily clinical practice.

All patients are treated with the Pantera Lux Paclitaxel releasing balloon.

Clinical follow ups at 1, 6 and 12 months after coronary intervention.

Inclusion criteria:

• Signed Patient Informed Consent / Data Release Form
• Patient eligible for percutaneous coronary intervention (PCI)
• Patient is older than 18 years of age

Exclusion Criteria

• Patient has a known allergy against appropriate anticoagulation / antiplatelet therapy
• Patients with known allergy against paclitaxel or BTHC
• Patients with a target lesion that was previously treated by brachytherapy
• Pregnant woman or lactating woman